Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
911 participants
INTERVENTIONAL
2018-01-08
2022-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\*\*On March 16th, 2020, the University of Alabama at Birmingham halted all onsite non-essential research in response to the Covid-19 pandemic. Since then, the study has begun to conduct all testing remotely through videoconferencing technology. In addition, another study group, remote DirectCAM (rDirectCAM), has been incorporated into the study to continue the 12-week program delivery for newly recruited participants via videoconferencing technology.\*\*
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
\*\*In response to the Covid-19 pandemic, the study aims to recruit 74 participants with MS into the rDirectCAM, where the 12-week program is delivered in real-time via videoconferencing technology. The rDirectCAM will determine if a telehealth rehabilitation program can have a similar effect as when the program is offered in person.\*\*
The outcomes that we hope to achieve through the proposed rehabilitation and exercise program, referred to as complementary alternative medicine, are improved physical activity, decreased pain and fatigue, and quality of life. We also seek to improve attitudes and behaviors related to physical activity, such as outcome expectations for physical activity, social support from family and friends for physical activity, self-efficacy (i.e., confidence in one's ability to be active), and self-regulation (i.e., setting exercise goals). We will examine the variation in outcomes by patient characteristics such as age and severity of disability to determine for whom the intervention is effective.
This project is important to patients with MS because it seeks to reduce their barriers to receiving exercise treatment and increase the convenience and appeal of such programs through technology. Furthermore, findings and resources from this study will be quickly provided to MS patients and clinicians across the United States (e.g., via training webinars through our National Center on Health, Physical Activity, and Disability \[NCHPAD\]) and thereby improve the quality and reach of exercise treatment for patients with MS.
The patient and stakeholder partners include MS patients, caretakers, and clinicians, who have been actively guiding the development of this project. In stakeholder meetings, members have provided insight into exercise treatment needs and preferences (e.g., individually tailored approaches that account for varying levels of mobility); outcomes of interest to the patient population (e.g., pain, fatigue, quality of life); and strategies for engaging/motivating participants with MS who may be discouraged and experiencing fatigue and pain (e.g., IVR calls and feedback). Moreover, their ongoing program satisfaction feedback will be important to our recruitment and retention success. Finally, the stakeholders will help make this project successful by continuing to emphasize the importance of long-term gains in health outcomes and promote (through NCHPAD) the sustainability of the program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DirectCAM
The DirectCAM arm receives the intervention content via therapists at participating clinics.
DirectCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks at a clinic with a therapist. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using handouts.
TeleCAM
The TeleCAM arm receives the intervention content at home using pre-loaded tablets and Interactive Voice Response (IVR) system technology.
TeleCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks at home via videos. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using the videos.
rDirectCAM
The rDirectCAM arm is being implemented in response to Covid-19. The rDirectCAM arm receives the intervention content delivered remotely in real-time by therapists via videoconferencing technology.
rDirectCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks by a therapist via videoconferencing technology. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using handouts.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DirectCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks at a clinic with a therapist. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using handouts.
TeleCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks at home via videos. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using the videos.
rDirectCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks by a therapist via videoconferencing technology. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using handouts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild to moderate disability (i.e., ambulate with/without assistive device, Patient-Determined Disease Steps \[PDDS\] 0 - 7
* Able to use arms/legs for exercise
Exclusion Criteria
* Cardiovascular disease event within the last six months, several pulmonary disease, and/or renal failure
* Active pressure ulcers
* Currently pregnant
* Within 30 days of receiving a rehabilitation program
* Already meeting physical activity guidelines (GLTEQ \> 24)
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Patient-Centered Outcomes Research Institute
OTHER
Alabama Neurology Associates, PC
OTHER
Lakeshore Foundation
OTHER
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Rimmer
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Upstream Rehabilitation Inc.
Athens, Alabama, United States
Upstream Rehabilitation Inc.
Bessemer, Alabama, United States
Tanner Foundation
Birmingham, Alabama, United States
Upstream Rehabilitation Inc.
Calera, Alabama, United States
Upstream Rehabilitation Inc.
Cullman, Alabama, United States
Southeast Alabama Medical Center Rehabilitation Services
Dothan, Alabama, United States
Gulf Coast Therapy
Fairhope, Alabama, United States
Gulf Coast Therapy
Foley, Alabama, United States
Encore Rehabilitation
Fort Payne, Alabama, United States
Upstream Rehabilitation Inc.
Gadsden, Alabama, United States
Therapy Achievements
Huntsville, Alabama, United States
Upstream Rehabilitation Inc.
Jacksonville, Alabama, United States
Upstream Rehabilitation Inc.
Jasper, Alabama, United States
Gulf Coast Therapy
Mobile, Alabama, United States
Montgomery East Physical Therapy
Montgomery, Alabama, United States
Upstream Rehabilitation Inc.
Muscle Shoals, Alabama, United States
Encore Rehabilitation
Phenix City, Alabama, United States
Upstream Rehabilitation Inc.
Tuscaloosa, Alabama, United States
Cornerstone Rehabilitation
Batesville, Mississippi, United States
Upstream Rehabilitation Inc.
Byram, Mississippi, United States
Upstream Rehabilitation Inc.
Canton, Mississippi, United States
Upstream Rehabilitation Inc.
Columbus, Mississippi, United States
Upstrem Rehabilitation
Forest, Mississippi, United States
Upstream Rehabilitation Inc.
Fulton, Mississippi, United States
River City Rehabilitation
Greenville, Mississippi, United States
Encore Rehabilitation
Grenada, Mississippi, United States
Upstream Rehabilitation Inc.
Hattiesburg, Mississippi, United States
Methodist Rehabilitation Center
Jackson, Mississippi, United States
Encore Rehabilitation
Ocean Springs, Mississippi, United States
North Sunflower Medical Center
Ruleville, Mississippi, United States
Cornerstone Rehabilitation
Southaven, Mississippi, United States
Upstream Rehabilitation Inc.
Starkville, Mississippi, United States
Upstream Rehabilitation Inc.
Tupelo, Mississippi, United States
Cornerstone Rehabilitation
Water Valley, Mississippi, United States
Upstream Rehabilitation Inc.
Bristol, Tennessee, United States
Upstream Rehabilitation Inc.
Cool Springs, Tennessee, United States
Upstream Rehabilitation Inc.
Gordonsville, Tennessee, United States
Upstream Rehabilitation Inc.
Knoxville, Tennessee, United States
Upstream Rehabilitation Inc.
Newport, Tennessee, United States
Upstream Rehabilitation Inc.
Winchester, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tracy TF, Young HJ, Lai B, Layton B, Stokes D, Fry M, Mehta T, Riser ES, Rimmer J. Supporting successful recruitment in a randomized control trial comparing clinic and home-based exercise among adults with multiple sclerosis. Res Involv Engagem. 2022 Jul 29;8(1):35. doi: 10.1186/s40900-022-00366-6.
Lai B, Chiu CY, Pounds E, Tracy T, Mehta T, Young HJ, Riser E, Rimmer J. COVID-19 Modifications for Remote Teleassessment and Teletraining of a Complementary Alternative Medicine Intervention for People With Multiple Sclerosis: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Jul 3;9(7):e18415. doi: 10.2196/18415.
Rimmer JH, Thirumalai M, Young HJ, Pekmezi D, Tracy T, Riser E, Mehta T. Rationale and design of the tele-exercise and multiple sclerosis (TEAMS) study: A comparative effectiveness trial between a clinic- and home-based telerehabilitation intervention for adults with multiple sclerosis (MS) living in the deep south. Contemp Clin Trials. 2018 Aug;71:186-193. doi: 10.1016/j.cct.2018.05.016. Epub 2018 May 30.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS-1511-33653
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
F161017003
Identifier Type: -
Identifier Source: org_study_id